Article ID Journal Published Year Pages File Type
5644631 Annales de Dermatologie et de Vénéréologie 2017 8 Pages PDF
Abstract
Botulin toxin appears to offer a therapeutic alternative in resistant forms of HHD, either as follow-on treatment or as an adjuvant to more radical forms of therapy such as CO2 laser. These retrospective data, as well as the optimal doses and injection rates, require further refinement by means of prospective studies.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, , , , ,